These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29498199)

  • 21. Hyphenation of coupled-column liquid chromatography and thermospray tandem mass spectrometry for the rapid determination of beta 2-agonist residues in bovine urine using direct large-volume sample injection. Set-up of single-residue methods for clenbuterol and salbutamol.
    Hogendoorn EA; van Zoonen P; Polettini A; Montagna M
    J Mass Spectrom; 1996 Apr; 31(4):418-26. PubMed ID: 8799286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of β-agonists clenbuterol and salbutamol in black and white mouse hair.
    Vulić A; Pleadin J; Perši N; Stojković R; Ivanković S
    J Anal Toxicol; 2011 Oct; 35(8):566-70. PubMed ID: 22004676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.
    Magro L; Arzenton E; Moretti U; Sottosanti L; Potenza S; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):69-75. PubMed ID: 27875920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
    Papiris S; Galavotti V; Sturani C
    Respiration; 1986; 49(2):101-8. PubMed ID: 3513269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of clenbuterol and salbutamol in the clinical control of the intercritical period in patients with recurrent bronchial asthma].
    Castelán Montalvo FA; Martínez Hernández G; Palmeros L
    Rev Alerg Mex (1987); 1989; 36(1):28-30. PubMed ID: 2749126
    [No Abstract]   [Full Text] [Related]  

  • 27. Patient Reporting in the EU: Analysis of EudraVigilance Data.
    Banovac M; Candore G; Slattery J; Houÿez F; Haerry D; Genov G; Arlett P
    Drug Saf; 2017 Jul; 40(7):629-645. PubMed ID: 28417320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late diagnosis of an outbreak of leanness-enhancing agent-related food poisoning.
    Wu ML; Deng JF; Chen Y; Chu WL; Hung DZ; Yang CC
    Am J Emerg Med; 2013 Oct; 31(10):1501-3. PubMed ID: 23928328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical significance of hair analysis of clenbuterol to discriminate therapeutic use from contamination.
    Krumbholz A; Anielski P; Gfrerer L; Graw M; Geyer H; Schänzer W; Dvorak J; Thieme D
    Drug Test Anal; 2014; 6(11-12):1108-16. PubMed ID: 25388545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism.
    McCormick C; Alexandre L; Thompson J; Mutungi G
    J Appl Physiol (1985); 2010 Dec; 109(6):1716-27. PubMed ID: 20864554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abuse of clenbuterol and its detection.
    Prezelj A; Obreza A; Pecar S
    Curr Med Chem; 2003 Feb; 10(4):281-90. PubMed ID: 12570701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clenbuterol and salbutamol accumulation in the liver of two different mouse strains.
    Vulić A; Pleadin J; Durgo K; Scortichini G; Stojković R
    J Anal Toxicol; 2014 Jun; 38(5):265-71. PubMed ID: 24661992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
    Aagaard L; Hallgreen CE; Hansen EH
    Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-agonists in animal feed. IV: Intercomparison study of a candidate reference confirmatory method.
    Leyssens L; Noben JP; Courtheyn D; Boenke A
    Food Addit Contam; 1996; 13(8):883-95. PubMed ID: 8950110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clenbuterol toxicity: a NSW poisons information centre experience.
    Brett J; Dawson AH; Brown JA
    Med J Aust; 2014 Mar; 200(4):219-21. PubMed ID: 24580525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes.
    Rodrigues-Neto AJ; Biazoni-Albaricci C; Ribeiro A; Lima S; Figueras A
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1471-1474. PubMed ID: 30039198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid immunoassay method for the determination of clenbuterol and salbutamol in blood.
    Pleadin J; Vulić A; Perši N; Terzić S; Andrišić M; Žarković I
    J Anal Toxicol; 2013 May; 37(4):241-5. PubMed ID: 23482498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.